Jan Kimpen

Jan Kimpen, is the Philips Chief Medical Officer, a position he has held since January 2016. As the leader of the global clinical team, Jan works with 40 clinicians and medical PhDs with the responsibility for advocacy, customer partnerships, clinical research and medical consulting, and he is responsible for the annual publication of the Philips Future Health Index. The team collaborates with Philips businesses, markets and enabling functions to advance clinical capabilities and customer growth opportunities. He is a strategic advisor for commercial and clinical strategy, market reimbursement, R&D roadmaps and partnerships and M&A. Jan chairs the Chief Medical and Scientific Office Leadership Team consisting of the clinical leaders of each Philips Cluster (Image-guided therapy, Precision Diagnosis, Connected Care, Personal Health) and in which the markets are represented. Together with the Medical Community of Practice across the company, this team will provide thought leadership for Philips on relevant clinical and medical topics such as the Quadruple Aim, Value-Based Care, healthcare governance and organization, hospital economics, payment and reimbursement and market access.

A frequent speaker on value-based care and digital innovation in healthcare, Jan participates in the WEF Global Future Council on Healthcare, the American Heart Association alliance and serves as Chairman of the Board at Sanara Ventures in Israel. Jan is Board Member of COCIR (formerly president, 2018-2020), the European trade union for imaging, healthcare informatics and radiotherapy.

Jan joined the company from the University Medical Center Utrecht – one of the largest healthcare organizations in the Netherlands – where he was a professor and chairman of Pediatrics before serving as CEO from 2009 to 2015.